By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Biosearch Technologies today said that it has licensed to Seegene patents covering its BHQ, CAL Fluor, and Quasar technologies.

Under terms of the deal, Novato, Calif.-based Biosearch also will manufacture both research and IVD-grade oligonucleotides for Seegene, a Korean firm that makes PCR-based molecular diagnostic products. Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: researchers classify pancreatic cancer into four subtypes using sequencing, and more.

Genotyping analysis of measles in Ontario indicates the strain there didn't originate from Disneyland or Europe.

The UK Medical Research Council says the proposed path of a new train line could affect research at the Francis Crick Institute.

The House of Lords in the UK approves a bill to allow mitochondrial donation.